HEADER TRANSFERASE 05-DEC-04 1Y6A TITLE CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: VEGFR-2, KINASE INSERT DOMAIN RECEPTOR, PROTEIN-TYROSINE COMPND 5 KINASE RECEPTOR FLK-1; COMPND 6 EC: 2.7.1.112; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KDR, FLK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.A.HARRIS,M.CHEUNG,R.N.HUNTER,M.L.BROWN,J.M.VEAL,R.T.NOLTE,L.WANG, AUTHOR 2 W.LIU,R.M.CROSBY,J.H.JOHNSON,A.H.EPPERLY,R.KUMAR,D.K.LUTTRELL, AUTHOR 3 J.A.STAFFORD REVDAT 5 14-FEB-24 1Y6A 1 REMARK REVDAT 4 11-OCT-17 1Y6A 1 REMARK REVDAT 3 13-JUL-11 1Y6A 1 VERSN REVDAT 2 24-FEB-09 1Y6A 1 VERSN REVDAT 1 07-JUN-05 1Y6A 0 JRNL AUTH P.A.HARRIS,M.CHEUNG,R.N.HUNTER,M.L.BROWN,J.M.VEAL,R.T.NOLTE, JRNL AUTH 2 L.WANG,W.LIU,R.M.CROSBY,J.H.JOHNSON,A.H.EPPERLY,R.KUMAR, JRNL AUTH 3 D.K.LUTTRELL,J.A.STAFFORD JRNL TITL DISCOVERY AND EVALUATION OF 2-ANILINO-5-ARYLOXAZOLES AS A JRNL TITL 2 NOVEL CLASS OF VEGFR2 KINASE INHIBITORS. JRNL REF J.MED.CHEM. V. 48 1610 2005 JRNL REFN ISSN 0022-2623 JRNL PMID 15743202 JRNL DOI 10.1021/JM049538W REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.87 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 20196 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.900 REMARK 3 FREE R VALUE TEST SET COUNT : 606 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1410 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.98 REMARK 3 BIN R VALUE (WORKING SET) : 0.2290 REMARK 3 BIN FREE R VALUE SET COUNT : 44 REMARK 3 BIN FREE R VALUE : 0.2520 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2099 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 150 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.20000 REMARK 3 B22 (A**2) : -0.26000 REMARK 3 B33 (A**2) : -1.94000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.191 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.156 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.116 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.424 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2217 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2023 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2998 ; 1.589 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4689 ; 0.867 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 256 ; 6.212 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 95 ;34.907 ;23.053 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 379 ;15.042 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;20.320 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 323 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2390 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 478 ; 0.008 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 456 ; 0.217 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1981 ; 0.190 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1054 ; 0.185 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1131 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 108 ; 0.256 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 4 ; 0.084 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 31 ; 0.170 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.341 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1683 ; 1.261 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 525 ; 0.190 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2097 ; 1.426 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1103 ; 2.008 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 901 ; 2.716 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 819 A 920 REMARK 3 ORIGIN FOR THE GROUP (A): 2.5880 33.6920 6.1600 REMARK 3 T TENSOR REMARK 3 T11: -0.0526 T22: -0.0432 REMARK 3 T33: -0.0561 T12: -0.0037 REMARK 3 T13: 0.0054 T23: -0.0137 REMARK 3 L TENSOR REMARK 3 L11: 1.2565 L22: 2.3263 REMARK 3 L33: 2.7065 L12: 0.1901 REMARK 3 L13: 0.0922 L23: 0.6597 REMARK 3 S TENSOR REMARK 3 S11: -0.0121 S12: 0.0070 S13: 0.0324 REMARK 3 S21: -0.0310 S22: -0.0240 S23: 0.2205 REMARK 3 S31: -0.0837 S32: -0.0894 S33: 0.0361 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 921 A 1165 REMARK 3 ORIGIN FOR THE GROUP (A): 7.7760 41.4910 32.2770 REMARK 3 T TENSOR REMARK 3 T11: -0.0015 T22: -0.0551 REMARK 3 T33: -0.1163 T12: -0.0025 REMARK 3 T13: 0.0265 T23: -0.0436 REMARK 3 L TENSOR REMARK 3 L11: 0.7801 L22: 2.7765 REMARK 3 L33: 3.1824 L12: 0.2252 REMARK 3 L13: 0.3939 L23: 1.7562 REMARK 3 S TENSOR REMARK 3 S11: -0.0694 S12: -0.0135 S13: 0.0243 REMARK 3 S21: 0.2004 S22: -0.0596 S23: 0.1139 REMARK 3 S31: 0.1319 S32: -0.1346 S33: 0.1290 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1Y6A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-DEC-04. REMARK 100 THE DEPOSITION ID IS D_1000031169. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20720 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.37600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.86600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.23650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.28500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.23650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.86600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.28500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 804 REMARK 465 ASP A 805 REMARK 465 PRO A 806 REMARK 465 ASP A 807 REMARK 465 GLU A 808 REMARK 465 LEU A 809 REMARK 465 PRO A 810 REMARK 465 LEU A 811 REMARK 465 ASP A 812 REMARK 465 GLU A 813 REMARK 465 HIS A 814 REMARK 465 CYS A 815 REMARK 465 GLU A 816 REMARK 465 ARG A 817 REMARK 465 GLY A 841 REMARK 465 ALA A 842 REMARK 465 PHE A 843 REMARK 465 GLY A 844 REMARK 465 LYS A 869 REMARK 465 GLU A 870 REMARK 465 GLY A 871 REMARK 465 ALA A 872 REMARK 465 LYS A 937 REMARK 465 THR A 938 REMARK 465 LYS A 939 REMARK 465 GLY A 940 REMARK 465 ALA A 941 REMARK 465 ARG A 942 REMARK 465 PHE A 943 REMARK 465 ARG A 944 REMARK 465 GLN A 945 REMARK 465 GLY A 946 REMARK 465 LYS A 947 REMARK 465 ASP A 948 REMARK 465 TYR A 949 REMARK 465 VAL A 950 REMARK 465 GLY A 951 REMARK 465 ALA A 952 REMARK 465 ILE A 953 REMARK 465 PRO A 954 REMARK 465 VAL A 955 REMARK 465 ASP A 956 REMARK 465 LEU A 957 REMARK 465 LYS A 958 REMARK 465 ARG A 959 REMARK 465 ARG A 960 REMARK 465 LEU A 961 REMARK 465 ASP A 962 REMARK 465 SER A 963 REMARK 465 ILE A 964 REMARK 465 THR A 965 REMARK 465 SER A 966 REMARK 465 SER A 967 REMARK 465 GLN A 968 REMARK 465 SER A 969 REMARK 465 SER A 970 REMARK 465 ALA A 971 REMARK 465 SER A 972 REMARK 465 SER A 973 REMARK 465 GLY A 974 REMARK 465 PHE A 975 REMARK 465 VAL A 976 REMARK 465 GLU A 977 REMARK 465 GLU A 978 REMARK 465 LYS A 979 REMARK 465 SER A 980 REMARK 465 LEU A 981 REMARK 465 SER A 982 REMARK 465 ASP A 983 REMARK 465 VAL A 984 REMARK 465 GLU A 985 REMARK 465 GLU A 986 REMARK 465 GLU A 987 REMARK 465 GLU A 988 REMARK 465 ALA A 989 REMARK 465 PRO A 990 REMARK 465 GLU A 991 REMARK 465 ASP A 992 REMARK 465 LEU A 993 REMARK 465 TYR A 994 REMARK 465 LYS A 995 REMARK 465 GLY A 1046 REMARK 465 LEU A 1047 REMARK 465 ALA A 1048 REMARK 465 ARG A 1049 REMARK 465 ASP A 1050 REMARK 465 ILE A 1051 REMARK 465 TYR A 1052 REMARK 465 LYS A 1053 REMARK 465 ASP A 1054 REMARK 465 PRO A 1055 REMARK 465 ASP A 1056 REMARK 465 TYR A 1057 REMARK 465 VAL A 1058 REMARK 465 ARG A 1059 REMARK 465 LYS A 1060 REMARK 465 GLY A 1061 REMARK 465 ASP A 1062 REMARK 465 ALA A 1063 REMARK 465 ARG A 1064 REMARK 465 LEU A 1065 REMARK 465 ALA A 1166 REMARK 465 GLN A 1167 REMARK 465 GLN A 1168 REMARK 465 ASP A 1169 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 840 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB CYS A 860 O HOH A 151 1.97 REMARK 500 SG CYS A 1005 O HOH A 153 2.08 REMARK 500 O HOH A 15 O HOH A 133 2.10 REMARK 500 O HOH A 5 O HOH A 151 2.11 REMARK 500 O HOH A 74 O HOH A 103 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 856 -3.25 72.89 REMARK 500 ALA A 858 49.26 -83.94 REMARK 500 ARG A1025 -16.64 81.96 REMARK 500 SER A1035 -164.96 -106.70 REMARK 500 ASP A1044 73.10 -103.71 REMARK 500 ARG A1078 14.94 59.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AAZ A 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1VR2 RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITHOUT LIGAND REMARK 900 RELATED ID: 1Y6B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL- REMARK 900 OXAZOLE INHIBITOR DBREF 1Y6A A 804 1169 UNP P35968 VGFR2_HUMAN 806 1171 SEQRES 1 A 366 MET ASP PRO ASP GLU LEU PRO LEU ASP GLU HIS CYS GLU SEQRES 2 A 366 ARG LEU PRO TYR ASP ALA SER LYS TRP GLU PHE PRO ARG SEQRES 3 A 366 ASP ARG LEU LYS LEU GLY LYS PRO LEU GLY ARG GLY ALA SEQRES 4 A 366 PHE GLY GLN VAL ILE GLU ALA ASP ALA PHE GLY ILE ASP SEQRES 5 A 366 LYS THR ALA THR CYS ARG THR VAL ALA VAL LYS MET LEU SEQRES 6 A 366 LYS GLU GLY ALA THR HIS SER GLU HIS ARG ALA LEU MET SEQRES 7 A 366 SER GLU LEU LYS ILE LEU ILE HIS ILE GLY HIS HIS LEU SEQRES 8 A 366 ASN VAL VAL ASN LEU LEU GLY ALA CYS THR LYS PRO GLY SEQRES 9 A 366 GLY PRO LEU MET VAL ILE VAL GLU PHE CYS LYS PHE GLY SEQRES 10 A 366 ASN LEU SER THR TYR LEU ARG SER LYS ARG ASN GLU PHE SEQRES 11 A 366 VAL PRO TYR LYS THR LYS GLY ALA ARG PHE ARG GLN GLY SEQRES 12 A 366 LYS ASP TYR VAL GLY ALA ILE PRO VAL ASP LEU LYS ARG SEQRES 13 A 366 ARG LEU ASP SER ILE THR SER SER GLN SER SER ALA SER SEQRES 14 A 366 SER GLY PHE VAL GLU GLU LYS SER LEU SER ASP VAL GLU SEQRES 15 A 366 GLU GLU GLU ALA PRO GLU ASP LEU TYR LYS ASP PHE LEU SEQRES 16 A 366 THR LEU GLU HIS LEU ILE CYS TYR SER PHE GLN VAL ALA SEQRES 17 A 366 LYS GLY MET GLU PHE LEU ALA SER ARG LYS CYS ILE HIS SEQRES 18 A 366 ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU SER GLU LYS SEQRES 19 A 366 ASN VAL VAL LYS ILE CYS ASP PHE GLY LEU ALA ARG ASP SEQRES 20 A 366 ILE TYR LYS ASP PRO ASP TYR VAL ARG LYS GLY ASP ALA SEQRES 21 A 366 ARG LEU PRO LEU LYS TRP MET ALA PRO GLU THR ILE PHE SEQRES 22 A 366 ASP ARG VAL TYR THR ILE GLN SER ASP VAL TRP SER PHE SEQRES 23 A 366 GLY VAL LEU LEU TRP GLU ILE PHE SER LEU GLY ALA SER SEQRES 24 A 366 PRO TYR PRO GLY VAL LYS ILE ASP GLU GLU PHE CYS ARG SEQRES 25 A 366 ARG LEU LYS GLU GLY THR ARG MET ARG ALA PRO ASP TYR SEQRES 26 A 366 THR THR PRO GLU MET TYR GLN THR MET LEU ASP CYS TRP SEQRES 27 A 366 HIS GLY GLU PRO SER GLN ARG PRO THR PHE SER GLU LEU SEQRES 28 A 366 VAL GLU HIS LEU GLY ASN LEU LEU GLN ALA ASN ALA GLN SEQRES 29 A 366 GLN ASP HET AAZ A 201 62 HETNAM AAZ N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2- HETNAM 2 AAZ PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE FORMUL 2 AAZ C23 H21 N3 O4 S FORMUL 3 HOH *150(H2 O) HELIX 1 1 ASP A 821 GLU A 826 1 6 HELIX 2 2 PRO A 828 ASP A 830 5 3 HELIX 3 3 THR A 873 GLY A 891 1 19 HELIX 4 4 ASN A 921 LYS A 929 1 9 HELIX 5 5 THR A 999 ARG A 1020 1 22 HELIX 6 6 ALA A 1028 ARG A 1030 5 3 HELIX 7 7 GLU A 1036 ASN A 1038 5 3 HELIX 8 8 PRO A 1066 MET A 1070 5 5 HELIX 9 9 ALA A 1071 ARG A 1078 1 8 HELIX 10 10 THR A 1081 SER A 1098 1 18 HELIX 11 11 ASP A 1110 GLY A 1120 1 11 HELIX 12 12 THR A 1130 TRP A 1141 1 12 HELIX 13 13 GLU A 1144 ARG A 1148 5 5 HELIX 14 14 THR A 1150 ASN A 1165 1 16 SHEET 1 A 5 LEU A 832 GLY A 839 0 SHEET 2 A 5 VAL A 846 PHE A 852 -1 O VAL A 846 N LEU A 838 SHEET 3 A 5 CYS A 860 MET A 867 -1 O VAL A 865 N ILE A 847 SHEET 4 A 5 MET A 911 GLU A 915 -1 O VAL A 914 N ALA A 864 SHEET 5 A 5 LEU A 899 CYS A 903 -1 N LEU A 900 O ILE A 913 SHEET 1 B 2 ILE A1032 LEU A1034 0 SHEET 2 B 2 VAL A1040 ILE A1042 -1 O LYS A1041 N LEU A1033 SITE 1 AC1 16 LEU A 838 ARG A 840 VAL A 846 ALA A 864 SITE 2 AC1 16 LYS A 866 GLU A 883 VAL A 912 VAL A 914 SITE 3 AC1 16 GLU A 915 PHE A 916 CYS A 917 LYS A 918 SITE 4 AC1 16 GLY A 920 ASN A 921 LEU A1033 PHE A1045 CRYST1 37.732 94.570 96.473 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026503 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010574 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010366 0.00000